
Bravecto 1-MONTH is an FDA-approved preparation containing Bravecto 1-MONTH, for veterinary use. Available by prescription.
Chew treats are flavored, soft treats that contain your pet’s medication—making giving meds as easy as offering a snack!
Use as directed by your veterinarian.
Bravecto 1-MONTH is a monthly oral chewable tablet considered in the context of flea and tick management in dogs. It is a prescription veterinary product in the isoxazoline ectoparasiticide class, typically considered for dogs at least 8 weeks of age and weighing at least 2 kg. Administering with food supports bioavailability. Your veterinarian will determine whether this product is appropriate based on your dog's individual health history and parasite risk profile.
At a pharmacological level, fluralaner is considered to work by inhibiting GABA-gated chloride channels in the parasite's central nervous system. This mechanism is associated with blocking pre- and postsynaptic chloride ion transfer across cell membranes, leading to neuronal hyperexcitation in susceptible insects and ticks. Insects and ticks must feed on the animal to be exposed to fluralaner. The monthly format acts to maintain a consistent protection interval when administered as directed. Your veterinarian is the right person to guide the integration of this product into your pet's parasite prevention protocol.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
Adverse effects reported with isoxazoline-class products include vomiting, diarrhea, inappetence and lethargy. The FDA has noted that isoxazoline-class ectoparasiticides have the potential to be associated with neurologic adverse effects including muscle tremors, ataxia and seizures, even at labeled dosages. Extra caution is considered in patients with a history of seizures or other neurologic conditions. Contact your veterinarian promptly if any neurologic signs are observed following administration.
This product is intended for use in dogs only and should not be administered to cats. Always administer with food. Ensure your veterinarian has a complete health history for your pet, including any current medications, before starting this product. Your veterinarian will provide guidance on the appropriate monthly schedule and whether this product is the right fit for your pet's individual needs.
Yes. Bravecto 1-MONTH is a prescription veterinary product. Mixlab verifies all authorizations from a licensed veterinarian before dispensing.
Standard Bravecto chewable tablets are designed for a 12-week protection interval, while Bravecto 1-MONTH is formulated for a monthly (approximately 4-week) dosing schedule. Your veterinarian will recommend the appropriate format based on your dog's needs.
Yes. Bravecto 1-MONTH chewable tablets should be administered with food. Giving the tablet with a meal supports proper absorption of the active ingredient.
Dogs with a history of seizures or other neurologic conditions require extra caution with isoxazoline-class products. Discuss your dog's full neurologic history with your veterinarian before starting this product.
No. Bravecto 1-MONTH is formulated for dogs only and should not be administered to cats.




